Brokerages forecast that Karyopharm Therapeutics Inc (NASDAQ:KPTI) will report sales of $1.15 million for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for Karyopharm Therapeutics’ earnings. The lowest sales estimate is $50,000.00 and the highest is $2.46 million. Karyopharm Therapeutics posted sales of $1.53 million in the same quarter last […]
